Nuwellis Inc (NASDAQ: NUWE)’s stock price has increased by 34.46 compared to its previous closing price of 1.48. However, the company has seen a 43.17% increase in its stock price over the last five trading sessions. globenewswire.com reported 2024-09-25 that MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that President and Chief Executive Officer Nestor Jaramillo will participate in ROTH Capital Partners’ third annual ROTH Healthcare Opportunities Conference on Wednesday, October 9, 2024.
Is It Worth Investing in Nuwellis Inc (NASDAQ: NUWE) Right Now?
The stock has a 36-month beta value of 0.45. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NUWE is 1.12M, and at present, short sellers hold a 15.81% of that float. On October 21, 2024, the average trading volume of NUWE was 744.70K shares.
NUWE’s Market Performance
The stock of Nuwellis Inc (NUWE) has seen a 43.17% increase in the past week, with a 57.94% rise in the past month, and a -52.05% fall in the past quarter. The volatility ratio for the week is 12.50%, and the volatility levels for the past 30 days are at 16.37% for NUWE. The simple moving average for the past 20 days is 40.34% for NUWE’s stock, with a -77.29% simple moving average for the past 200 days.
Analysts’ Opinion of NUWE
Many brokerage firms have already submitted their reports for NUWE stocks, with ROTH MKM repeating the rating for NUWE by listing it as a “Buy.” The predicted price for NUWE in the upcoming period, according to ROTH MKM is $17 based on the research report published on July 29, 2024 of the current year 2024.
NUWE Trading at 35.44% from the 50-Day Moving Average
After a stumble in the market that brought NUWE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.45% of loss for the given period.
Volatility was left at 16.37%, however, over the last 30 days, the volatility rate increased by 12.50%, as shares surge +37.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.53% lower at present.
During the last 5 trading sessions, NUWE rose by +28.78%, which changed the moving average for the period of 200-days by -91.32% in comparison to the 20-day moving average, which settled at $1.4080. In addition, Nuwellis Inc saw -90.21% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NUWE
Current profitability levels for the company are sitting at:
- -1.53 for the present operating margin
- 0.6 for the gross margin
The net margin for Nuwellis Inc stands at -2.26. The total capital return value is set at -6.36. Equity return is now at value -987.45, with -192.57 for asset returns.
Based on Nuwellis Inc (NUWE), the company’s capital structure generated -0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -18.65. The debt to equity ratio resting at -0.1. The interest coverage ratio of the stock is -1.52.
Currently, EBITDA for the company is -17.27 million with net debt to EBITDA at 0.03. When we switch over and look at the enterprise to sales, we see a ratio of 0.35. The receivables turnover for the company is 6.98for trailing twelve months and the total asset turnover is 1.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.20.
Conclusion
To sum up, Nuwellis Inc (NUWE) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
